Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Chemical Biology & Drug Design|December 21, 2016
New 3-alkylpyridine marine alkaloid analogues as promising antitumor agents against the CD44+/high /CD24-/low subset of triple-negative breast cancer cell lineAline Brito de Lima, Camila de Souza Barbosa, Alessandra Mirtes Marques Neves Gonçalves, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|February 8, 2021
Metabolic activation enhances the cytotoxicity, genotoxicity and mutagenicity of two synthetic alkaloids with selective effects against human tumour cell linesJúlia Teixeira de Oliveira, Filipe Nogueira Franco, Kimberly Brito Tecchio, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|September 26, 2024
Evaluation of the in vivo acute toxicity and in vitro genotoxicity and mutagenicity of synthetic β-carboline alkaloids with selective cytotoxic activity against ovarian and breast cancer cell linesKimberly Brito Tecchio, Fernanda de Moura Alves, Janaina Domingas Alves, et al.
Marine Drugs|January 24, 2025
Exploring Antibacterial Properties of Marine Sponge-Derived Natural Compounds: A Systematic ReviewCintia Cristina Santi Martignago, Camila de Souza Barbosa, Homero Garcia Motta, et al.
ACS Omega|July 20, 2018
Target-Guided Synthesis and Antiplasmodial Evaluation of a New Fluorinated 3-Alkylpyridine Marine Alkaloid AnalogCamila de Souza Barbosa, Daniel Silqueira Martins Guimarães, Alessandra Mirtes Marques Neves Gonçalves, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|January 9, 2018
Synthesis and evaluation of the mutagenicity of 3-alkylpyridine marine alkaloid analogues with anticancer potentialMaria Cristina S Barbosa, Camila de Souza Barbosa, Júlia T de Oliveira, et al.
Marine Drugs|August 5, 2014
Synthesis and biological evaluation of novel 3-alkylpyridine marine alkaloid analogs with promising anticancer activityAlessandra Mirtes Marques Neves Gonçalves, Aline Brito de Lima, Maria Cristina da Silva Barbosa, et al.
Pathogens (Basel, Switzerland)|December 23, 2022
Rational-Based Discovery of Novel β-Carboline Derivatives as Potential Antimalarials: From In Silico Identification of Novel Targets to Inhibition of Experimental Cerebral MalariaFernanda de Moura Alves, Jessica Correa Bezerra Bellei, Camila de Souza Barbosa, et al.
Pageof 1